Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > 15 Annual International OV Conference in Banff in Nov 2023
View:
Post by askretka on Mar 25, 2023 3:50am

15 Annual International OV Conference in Banff in Nov 2023

https://cumming.ucalgary.ca/research/immune-oncology-initiative/iovc-2023<br /> <br /> <span style="color: rgb(61, 61, 61); font-family: &quot;Proxima Nova&quot;, Arial, Helvetica, sans-serif; font-size: 16px; text-align: center;">The 15th Annual International Oncolytic Virotherapy Conference is taking place in beautiful Banff, Alberta at the Rimrock Resort. Please join us Saturday November 11 - Tuesday November 14 as we delve into the latest advancements in oncolytic virotherapy from scientific, clinical and industry perspectives</span>
Comment by t898an on Mar 26, 2023 12:59am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities